Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit - Reuters
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMlBfbG1yY051SHNUNHdybEJTNEt2VHowMk9UMy1abmpqWnRONG1QNVFKODluMi00Y3NLN2V4ejNxTWZrRGVRc3NGVkRYbVdDRFZJM1VvTktuQzAwTnBIRzlnOUJJQW9STHJzNVh1VmhWalVlcTNudGVIMzQ2ck1kTVBhV3E1RTBReEJpbm8taVZlc0tKLS10d2NEOWhxdUd6RXV4VjFqQUYxNm9VdFdNQWp6OHZpbE1P?oc=5" target="_blank">Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMEli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMWalmart settles US government's opioid lawsuit, which sought billions, for $50 million - Reuters
Walmart settles US government's opioid lawsuit, which sought billions, for $50 million Reuters
August 28, 2026 at 10:29 PM